CDC fields reflect 2022 ART reporting. FDA HCT/P establishment registration does not establish compliance, approval, licensure, ART reporting, services, safety, success, or current operation. First-party prices appear only for three reviewed exact clinic matches and retain package components; they are not individualized quotes. Patient characteristics and treatment methods affect outcomes; verify current facts with the clinic and qualified clinicians.
Match the outcome to the age band
Use the patient age band and treatment pathway that apply to the decision. A clinic-wide headline rate can combine unlike patients and procedures.
Keep the denominator attached
Small denominators create volatile percentages. Read each rate with intended retrievals, reporting year, exclusions, and the CDC definition.
Treat cycle volume as context
Volume may indicate experience with a workflow, but it does not establish better outcomes, access, laboratory quality, or a good fit for a specific diagnosis.
Compare the actual treatment plan
Ask who will direct care, laboratory arrangements, testing and medication assumptions, single-embryo-transfer policy, cancellation policy, genetic testing, total expected cost, refund terms, and monitoring logistics.
Quick answers
Common interpretation mistakes
Can a CDC rate predict my chance of success?
No. Age, diagnosis, ovarian reserve, treatment history, and protocol all matter.
Does higher cycle volume mean better care?
No. Volume is descriptive and should not be used as a quality score.
Are these current clinic facts?
CDC fields reflect 2022 reporting. The FDA layer reflects the current query observation date, but registration does not establish current operation or services.
Build a source-linked shortlist
Search the full dataset, open individual records, and verify time-sensitive details with the original source.
Open the map